Analysis of the rs10046 polymorphism of aromatase (CYP19) in premenopausal onset of human breast cancer.
about
Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women.Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities StudyRole of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy.Polymorphism C242T in the Cyp19 gene in meat sheep.Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer.
P2860
Analysis of the rs10046 polymorphism of aromatase (CYP19) in premenopausal onset of human breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Analysis of the rs10046 polymo ...... onset of human breast cancer.
@en
Analysis of the rs10046 polymorphism of aromatase
@nl
type
label
Analysis of the rs10046 polymo ...... onset of human breast cancer.
@en
Analysis of the rs10046 polymorphism of aromatase
@nl
prefLabel
Analysis of the rs10046 polymo ...... onset of human breast cancer.
@en
Analysis of the rs10046 polymorphism of aromatase
@nl
P2860
P50
P356
P1476
Analysis of the rs10046 polymo ...... onset of human breast cancer.
@en
P2093
Christian Schneeberger
Maurice Mogg
P2860
P304
P356
10.3390/IJMS15010712
P407
P577
2014-01-07T00:00:00Z